macro

RBC Keeps Gilead at Sector Perform and Lifts Target to $131

Dow Jones Newswires, citing Benzinga, reports RBC Capital kept Gilead Sciences at Sector Perform and raised its price target to $131 per share.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

Dow Jones Newswires, citing Benzinga ratings data, reports that RBC Capital kept its Sector Perform rating on Gilead Sciences but raised the price target on the stock to $131 per share from $126.

In the same batch of analyst updates, the firm also maintained Sector Perform ratings on Kymera Therapeutics and Incyte. The update does not give target changes for those two companies.

All three notices were published on October 30, 2026, between 16:26 and 16:33 GMT.

why it matters

Routine analyst actions like these rarely move the broader market. For Gilead, the point is a higher target with an unchanged rating, while for Kymera and Incyte the news changes little.

tags

instruments

GILDKYMRINCY

sources

  1. Gilead Sciences Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 16:26 UTC
  2. Kymera Therapeutics Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 16:33 UTC
  3. Incyte Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 16:29 UTC
  4. PTC Therapeutics Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 17:06 UTC
  5. Pinterest Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 17:12 UTC
  6. Hanover Insurance Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 17:31 UTC
  7. Vulcan Materials Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 17:37 UTC
  8. Trane Technologies Is Maintained at Sector Perform by RBC Capital — Dow Jones Newswires, 30 October 2026 at 17:35 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗